118 related articles for article (PubMed ID: 29304228)
1. Prognostic Value of Free Triiodothyronine Level in Patients With Hypertrophic Obstructive Cardiomyopathy.
Zhang K; Meng X; Wang W; Zheng J; An S; Wang S; Qi Y; Gao C; Tang YD
J Clin Endocrinol Metab; 2018 Mar; 103(3):1198-1205. PubMed ID: 29304228
[TBL] [Abstract][Full Text] [Related]
2. [Long-term prognostic value of lowering in free triiodothyronine in patients with hypertrophic cardiomyopathy].
Meng XB; Wang WY; Zhang K; Qi Y; An SM; Wang SY; Zheng JL; Yu QJ; Tang B; Wu R; Gao CY; Wang SY; Tang YD
Zhonghua Nei Ke Za Zhi; 2018 Apr; 57(4):258-263. PubMed ID: 29614583
[No Abstract] [Full Text] [Related]
3. Long-term prognostic value of combined free triiodothyronine and late gadolinium enhancement in nonischemic dilated cardiomyopathy.
Zhang K; Wang W; Zhao S; Katz SD; Iervasi G; Gerdes AM; Tang YD
Clin Cardiol; 2018 Jan; 41(1):96-103. PubMed ID: 29360143
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of combined measurement of brain natriuretic peptide and triiodothyronine in heart failure.
Passino C; Pingitore A; Landi P; Fontana M; Zyw L; Clerico A; Emdin M; Iervasi G
J Card Fail; 2009 Feb; 15(1):35-40. PubMed ID: 19181292
[TBL] [Abstract][Full Text] [Related]
5. Plasma Uric Acid as a Prognostic Marker in Patients With Hypertrophic Cardiomyopathy.
Zhu L; Wang J; Wang Y; Jia L; Sun K; Wang H; Zou Y; Tian T; Liu Y; Zou J; Hui R; Yuan Z; Song L
Can J Cardiol; 2015 Oct; 31(10):1252-8. PubMed ID: 26111667
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of FT3 to FT4 Ratio to Predict Mortality in Euthyroid Patients With Prior Cardiovascular Events Undergoing PCI: Five-Year Findings From a Large Single-Center Cohort Study.
Yuan D; Jia S; Zhu P; Zhang C; Liu Y; Liu R; Xu J; Tang X; Zhao X; Gao R; Yang Y; Xu B; Gao Z; Yuan J
Front Endocrinol (Lausanne); 2021; 12():700349. PubMed ID: 34290672
[TBL] [Abstract][Full Text] [Related]
7. Uric acid is associated with cardiac death in patients with hypertrophic obstructive cardiomyopathy.
Gao J; Shao CL; Meng XB; Wang WY; Zhang K; Wang JJ; Zheng MQ; Tang YD
J Geriatr Cardiol; 2021 Apr; 18(4):281-288. PubMed ID: 33995507
[TBL] [Abstract][Full Text] [Related]
8. Association Between Low T3 Syndrome and Poor Prognosis in Adult Patients With Acute Myocarditis.
Zhao Y; Wang W; Zhang K; Tang YD
Front Endocrinol (Lausanne); 2021; 12():571765. PubMed ID: 33763025
[TBL] [Abstract][Full Text] [Related]
9. Low T3 syndrome predicts more adverse events in patients with hypertrophic cardiomyopathy.
He CJ; Zhu CY; Fan HY; Qian YZ; Zhai CL; Hu HL
Clin Cardiol; 2023 Dec; 46(12):1569-1577. PubMed ID: 37711064
[TBL] [Abstract][Full Text] [Related]
10. Low triiodothyronine and survival in end-stage renal disease.
Zoccali C; Mallamaci F; Tripepi G; Cutrupi S; Pizzini P
Kidney Int; 2006 Aug; 70(3):523-8. PubMed ID: 16775599
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.
Funada A; Kanzaki H; Noguchi T; Morita Y; Sugano Y; Ohara T; Hasegawa T; Hashimura H; Ishibashi-Ueda H; Kitakaze M; Yasuda S; Ogawa H; Anzai T
Heart Vessels; 2016 May; 31(5):758-70. PubMed ID: 25820658
[TBL] [Abstract][Full Text] [Related]
12. [The prognostic value of free triiodothyronine/free thyroxine ratio in patients hospitalized with heart failure].
Zhou P; Huang LY; Zhai M; Huang Y; Zhuang XF; Liu HH; Zhang YH; Zhang J
Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(22):1679-1684. PubMed ID: 37302858
[No Abstract] [Full Text] [Related]
13. Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study.
Brozaitiene J; Mickuviene N; Podlipskyte A; Burkauskas J; Bunevicius R
BMC Cardiovasc Disord; 2016 Feb; 16():45. PubMed ID: 26892923
[TBL] [Abstract][Full Text] [Related]
14. Lower free triiodothyronine levels within the reference range are associated with higher cardiovascular mortality: An analysis of the NHANES.
Neves JS; Leitão L; Baeta Baptista R; Bigotte Vieira M; Magriço R; Viegas Dias C; Oliveira A; Falcão-Pires I; Lourenço A; Carvalho D; Leite-Moreira A
Int J Cardiol; 2019 Jun; 285():115-120. PubMed ID: 30879936
[TBL] [Abstract][Full Text] [Related]
15. Association between Thyroid Function and Prognosis of COVID-19: A Retrospective Observational Study.
Lang S; Liu Y; Qu X; Lu R; Fu W; Zhang W; Wang H; Hong T
Endocr Res; 2021 Nov; 46(4):170-177. PubMed ID: 34014139
[No Abstract] [Full Text] [Related]
16. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease.
Iervasi G; Pingitore A; Landi P; Raciti M; Ripoli A; Scarlattini M; L'Abbate A; Donato L
Circulation; 2003 Feb; 107(5):708-13. PubMed ID: 12578873
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of N-terminal pro-brain natriuretic Peptide in outpatients with hypertrophic cardiomyopathy.
D'Amato R; Tomberli B; Castelli G; Spoladore R; Girolami F; Fornaro A; Caldini A; Torricelli F; Camici P; Gensini GF; Cecchi F; Olivotto I
Am J Cardiol; 2013 Oct; 112(8):1190-6. PubMed ID: 23871673
[TBL] [Abstract][Full Text] [Related]
18. A low fT3 level as a prognostic marker in patients with acute myocardial infarctions.
Zhang B; Peng W; Wang C; Li W; Xu Y
Intern Med; 2012; 51(21):3009-15. PubMed ID: 23124142
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of Plasma High-Sensitivity C-Reactive Protein in Patients With Hypertrophic Cardiomyopathy.
Zhu L; Zou Y; Wang Y; Luo X; Sun K; Wang H; Jia L; Liu Y; Zou J; Yuan Z; Hui R; Kang L; Song L; Wang J
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28154166
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of red blood cell distribution width for mortality in patients with hypertrophic cardiomyopathy.
Wang Z; Chen X; He S
Clin Biochem; 2021 Oct; 96():19-25. PubMed ID: 34245695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
